Summit Medical Group Web Site

UPDATE 6/1/20:

In response to ever-changing challenges posed by the novel Coronavirus (COVID-19), our department is taking steps to ensure patient safety and optimize clinical outcomes. Our offices are open to serve your needs for live visits, and we also continue to offer telemedicine to support social distancing and facilitate timely and efficient care.

The following office protocols are in effect presently:

Therapies and Treatments:

• Patients scheduled for phototherapy (i.e. the "light box") and photodynamic therapy (i.e. blue and red light treatments) have been temporarily asked to postpone therapy. We aim to update our website in the near future with a date upon which these services will be offered.
• A large number of our patients are treated with "biologic" immune-targeting therapies to treat psoriasis, eczema, blistering diseases, hidradenitis suppurativa and other inflammatory skin conditions.  These medications include: TNF alpha inhibitors (Remicade (infliximab,) Enbrel (etanercept,) Humira (adalimumab,) and Cimzia (certolizumab); IL-17 blockers Cosentyx (secukinimab,) Taltz (ixekizumab,) and Siliq (brodalumab); and IL-23 blockers including Stelara (ustekinumab,) Ilumya (tildrakizumab-asmn,) Skyrizi (risankizumab-rzaa), and Tremfya (guselkumab.)  We advise that patients on such medications contact the prescribing physician's office for current recommendations and treatment plans.  Such plans can, in many instances, be discussed via telemedicine.
• Patients with rashes will be triaged by our trained nurses and advised either telemedicine visits with physicians or live visits with physicians.  Your safety is our primary concern.
• We are happy to schedule elective Cosmetic and laser procedures at this time.